Bayer Stock News

Bayer DE000BAY0017 muss sich bis zu einer möglichen Zulassung seines Menopausen-Mittels Elinzanetant im lukrativen US-Markt noch gedulden.

The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German drugmaker said on Friday.

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Provides Regulatory Update on Elinzanetant for the Treatment of Moderate to Severe Hot Flashes Due to Menopause.

Bayer DE000BAY0017 darf sein Prostatakrebs-Medikament Nubeqa in der Europäischen Union zur Behandlung einer weiteren Patientengruppe verkaufen.

Germany's Bayer said on Wednesday that its supervisory board had extended the contract of CEO Bill Anderson until March 31, 2029.

Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside. The main risks are ongoing glyphosate litigation and pharma pricing pressures, but current valuation heavily discounts these concerns. Despite crop science headwinds and legacy litigation, core pharma brands and pipeline growth provide a foundation for recovery.

Beim Umbau des Agrarchemie- und Pharmakonzerns Bayer DE000BAY0017 bekommt der Vorstandsvorsitzende Bill Anderson mehr Zeit.

Eine neue Medikamentenzulassung in den USA hat den Aktien von Bayer DE000BAY0017 am Montag in einem schwachen Gesamtmarkt Auftrieb gegeben.